United States

Press Release

OraSure Technologies to Present at the UBS Global Healthcare Virtual Conference

May 18, 2021 at 7:00 AM EDT

BETHLEHEM, Pa., May 18, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will participate in a fireside chat at the UBS Global Healthcare Virtual Conference. The conference will be simultaneously webcast over the Internet.

Dr. Tang is scheduled to speak on May 26, 2021, at 2:00 PM EDT. The live webcast and a replay of the presentation can be accessed by going to OraSure Technologies’ web site, and clicking on the Investor Info link. A replay of the webcast will be available on OraSure Technologies’ web site for 14 days. Alternatively, you can access the live webcast of the presentation here.

About OraSure Technologies

OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. OraSure, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers. For more information on OraSure Technologies, please visit

Company contacts:

Scott Gleason
SVP of IR and Corp. Communications

Jeanne Mell
VP Corporate Communications